- Works count
- 1,064
- Citation count
- 39,438
- H-index
- 106
- i10-index
- 451
Research interests
Publications
Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study
Sleep Medicine · 2021 · https://doi.org/10.1016/j.sleep.2021.07.035
Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts
Sleep Medicine Reviews · 2020 · https://doi.org/10.1016/j.smrv.2020.101306
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Brain · 2019 · https://doi.org/10.1093/brain/awz030
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Nature Reviews Neurology · 2019 · https://doi.org/10.1038/s41582-019-0226-9
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
Clinical and Translational Allergy · 2019 · https://doi.org/10.1186/s13601-019-0279-2
Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy
Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-07229-3
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis
The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30327-7
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis
The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30327-7
National Sleep Foundation's sleep quality recommendations: first report
Sleep Health · 2016 · https://doi.org/10.1016/j.sleh.2016.11.006
Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study
Annals of Neurology · 2015 · https://doi.org/10.1002/ana.24385
DQB1 Locus Alone Explains Most of the Risk and Protection in Narcolepsy with Cataplexy in Europe
SLEEP · 2014 · https://doi.org/10.5665/sleep.3300
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(13)70225-4
ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
PLoS Genetics · 2013 · https://doi.org/10.1371/journal.pgen.1003270
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
Sleep Medicine · 2013 · https://doi.org/10.1016/j.sleep.2013.02.016
Clinical, polysomnographic and genome‐wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study
Journal of Sleep Research · 2013 · https://doi.org/10.1111/jsr.12044
A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study
Movement Disorders · 2012 · https://doi.org/10.1002/mds.25037
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy
Nature Genetics · 2010 · https://doi.org/10.1038/ng.647
EFNS guidelines on management of narcolepsy
European Journal of Neurology · 2006 · https://doi.org/10.1111/j.1468-1331.2006.01473.x
Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset
Annals of Neurology · 2004 · https://doi.org/10.1002/ana.20339
HLA and genetic susceptibility to sleepwalking
Molecular Psychiatry · 2003 · https://doi.org/10.1038/sj.mp.4001203
Kleine-Levin syndrome
Neurology · 2002 · https://doi.org/10.1212/01.wnl.0000036605.89977.d0
Age at onset of narcolepsy in two large populations of patients in France and Quebec
Neurology · 2001 · https://doi.org/10.1212/wnl.57.11.2029
Current projects
No projects listed.